Acceptability of a digital health application to empower persons with multiple sclerosis with moderate to severe disability: single-arm prospective pilot study

Abstract Background Many persons with multiple sclerosis (pwMS) desire to learn how health behaviour changes (e.g., dietary adjustments, physical activity, improvements in stress management) might help them manage their disease. Previous research has shown that certain health behaviour changes can i...

Full description

Bibliographic Details
Main Authors: Max Kutzinski, Nicole Krause, Karin Riemann-Lorenz, Björn Meyer, Christoph Heesen
Format: Article
Language:English
Published: BMC 2023-10-01
Series:BMC Neurology
Subjects:
Online Access:https://doi.org/10.1186/s12883-023-03434-w
_version_ 1797452192719831040
author Max Kutzinski
Nicole Krause
Karin Riemann-Lorenz
Björn Meyer
Christoph Heesen
author_facet Max Kutzinski
Nicole Krause
Karin Riemann-Lorenz
Björn Meyer
Christoph Heesen
author_sort Max Kutzinski
collection DOAJ
description Abstract Background Many persons with multiple sclerosis (pwMS) desire to learn how health behaviour changes (e.g., dietary adjustments, physical activity, improvements in stress management) might help them manage their disease. Previous research has shown that certain health behaviour changes can improve quality of life (QoL), fatigue and other MS outcomes. Digital health applications may be well suited to deliver relevant health behavioural interventions because of their accessibility and flexibility. The digital health application “levidex” was designed to facilitate health behaviour change by offering evidence-based patient information and cognitive-behavioural therapy techniques to pwMS. By doing so, levidex aims to improve QoL and MS symptoms such as fatigue and mental health. Objectives A previous study reported on the development of levidex; this non-randomised pilot study examined the feasibility (practicability and acceptability) of levidex in pwMS with moderate to severe disability. Furthermore, the intervention’s impact on empowerment, stress management, and relevant health behaviours (e.g., dietary behaviour, physical activity) was explored. Methods levidex was originally developed for newly diagnosed pwMS in the first year after diagnosis and eventually modified to offer access to pwMS with moderate to severe disability. Participants (n = 43) with an Expanded Disability Status Scale between 3.5 and 7.5 and a disease duration of more than one year were eligible to participate. The intervention was used over a period of six months with measurement time points at baseline, month 3 and month 6. Results Out of 38 participants who completed the six-month intervention period, 18 (47.4%) completed all 16 modules and 9 (23.7%) reached modules 13–16, the long-term maintenance part of levidex. Participants rated levidex positively in terms of practicability and acceptability and had only few points of criticism such as to include more physical exercise routine suggestions suitable for participants with severe impairment. Data on secondary endpoints showed no significant changes. Conclusion This pilot study provided evidence for the practicability and acceptability of levidex, a digital health application designed to facilitate health behaviour change in pwMS with moderate to severe disability. Adequately powered randomised controlled studies with longer follow-up periods are needed to clarify the benefit of levidex in pwMS with moderate to severe disability. Trial registration German Clinical Trials Register (DRKS) DRKS00032667 (14/09/2023); Retrospectively registered.
first_indexed 2024-03-09T15:05:15Z
format Article
id doaj.art-bb768a9427a3459bb5169eaad7327bf5
institution Directory Open Access Journal
issn 1471-2377
language English
last_indexed 2024-03-09T15:05:15Z
publishDate 2023-10-01
publisher BMC
record_format Article
series BMC Neurology
spelling doaj.art-bb768a9427a3459bb5169eaad7327bf52023-11-26T13:42:09ZengBMCBMC Neurology1471-23772023-10-0123111310.1186/s12883-023-03434-wAcceptability of a digital health application to empower persons with multiple sclerosis with moderate to severe disability: single-arm prospective pilot studyMax Kutzinski0Nicole Krause1Karin Riemann-Lorenz2Björn Meyer3Christoph Heesen4Institute of Neuroimmunology and Multiple Sclerosis (INIMS), University Medical Center Hamburg-EppendorfInstitute of Neuroimmunology and Multiple Sclerosis (INIMS), University Medical Center Hamburg-EppendorfInstitute of Neuroimmunology and Multiple Sclerosis (INIMS), University Medical Center Hamburg-EppendorfResearch and Development Department, GAIA GroupInstitute of Neuroimmunology and Multiple Sclerosis (INIMS), University Medical Center Hamburg-EppendorfAbstract Background Many persons with multiple sclerosis (pwMS) desire to learn how health behaviour changes (e.g., dietary adjustments, physical activity, improvements in stress management) might help them manage their disease. Previous research has shown that certain health behaviour changes can improve quality of life (QoL), fatigue and other MS outcomes. Digital health applications may be well suited to deliver relevant health behavioural interventions because of their accessibility and flexibility. The digital health application “levidex” was designed to facilitate health behaviour change by offering evidence-based patient information and cognitive-behavioural therapy techniques to pwMS. By doing so, levidex aims to improve QoL and MS symptoms such as fatigue and mental health. Objectives A previous study reported on the development of levidex; this non-randomised pilot study examined the feasibility (practicability and acceptability) of levidex in pwMS with moderate to severe disability. Furthermore, the intervention’s impact on empowerment, stress management, and relevant health behaviours (e.g., dietary behaviour, physical activity) was explored. Methods levidex was originally developed for newly diagnosed pwMS in the first year after diagnosis and eventually modified to offer access to pwMS with moderate to severe disability. Participants (n = 43) with an Expanded Disability Status Scale between 3.5 and 7.5 and a disease duration of more than one year were eligible to participate. The intervention was used over a period of six months with measurement time points at baseline, month 3 and month 6. Results Out of 38 participants who completed the six-month intervention period, 18 (47.4%) completed all 16 modules and 9 (23.7%) reached modules 13–16, the long-term maintenance part of levidex. Participants rated levidex positively in terms of practicability and acceptability and had only few points of criticism such as to include more physical exercise routine suggestions suitable for participants with severe impairment. Data on secondary endpoints showed no significant changes. Conclusion This pilot study provided evidence for the practicability and acceptability of levidex, a digital health application designed to facilitate health behaviour change in pwMS with moderate to severe disability. Adequately powered randomised controlled studies with longer follow-up periods are needed to clarify the benefit of levidex in pwMS with moderate to severe disability. Trial registration German Clinical Trials Register (DRKS) DRKS00032667 (14/09/2023); Retrospectively registered.https://doi.org/10.1186/s12883-023-03434-weHealthModerate to severe disabilityAdvanced multiple sclerosisDigital health applicationLifestyle interventionHealth behaviour change
spellingShingle Max Kutzinski
Nicole Krause
Karin Riemann-Lorenz
Björn Meyer
Christoph Heesen
Acceptability of a digital health application to empower persons with multiple sclerosis with moderate to severe disability: single-arm prospective pilot study
BMC Neurology
eHealth
Moderate to severe disability
Advanced multiple sclerosis
Digital health application
Lifestyle intervention
Health behaviour change
title Acceptability of a digital health application to empower persons with multiple sclerosis with moderate to severe disability: single-arm prospective pilot study
title_full Acceptability of a digital health application to empower persons with multiple sclerosis with moderate to severe disability: single-arm prospective pilot study
title_fullStr Acceptability of a digital health application to empower persons with multiple sclerosis with moderate to severe disability: single-arm prospective pilot study
title_full_unstemmed Acceptability of a digital health application to empower persons with multiple sclerosis with moderate to severe disability: single-arm prospective pilot study
title_short Acceptability of a digital health application to empower persons with multiple sclerosis with moderate to severe disability: single-arm prospective pilot study
title_sort acceptability of a digital health application to empower persons with multiple sclerosis with moderate to severe disability single arm prospective pilot study
topic eHealth
Moderate to severe disability
Advanced multiple sclerosis
Digital health application
Lifestyle intervention
Health behaviour change
url https://doi.org/10.1186/s12883-023-03434-w
work_keys_str_mv AT maxkutzinski acceptabilityofadigitalhealthapplicationtoempowerpersonswithmultiplesclerosiswithmoderatetoseveredisabilitysinglearmprospectivepilotstudy
AT nicolekrause acceptabilityofadigitalhealthapplicationtoempowerpersonswithmultiplesclerosiswithmoderatetoseveredisabilitysinglearmprospectivepilotstudy
AT karinriemannlorenz acceptabilityofadigitalhealthapplicationtoempowerpersonswithmultiplesclerosiswithmoderatetoseveredisabilitysinglearmprospectivepilotstudy
AT bjornmeyer acceptabilityofadigitalhealthapplicationtoempowerpersonswithmultiplesclerosiswithmoderatetoseveredisabilitysinglearmprospectivepilotstudy
AT christophheesen acceptabilityofadigitalhealthapplicationtoempowerpersonswithmultiplesclerosiswithmoderatetoseveredisabilitysinglearmprospectivepilotstudy